Deutsch English Français

Contact

EP1131457

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1131457

EP1131457 - SYSTEMIC VIRAL/LIGAND GENE DELIVERY SYSTEM AND GENE THERAPY [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 12.08.2011 Database last updated on 18.10.2024
Most recent event Tooltip	28.09.2012	Lapse of the patent in a contracting state New state(s): LU	published on 31.10.2012 [2012/44]
Applicant(s)	For all designated states GEORGETOWN UNIVERSITY 37th and O Streets, N.W. Washington, DC 20057 / US
	For all designated states SynerGene Therapeutics, Inc. 9812 Falls Road, Suite 114 Potomac, MD 20854-3963 / US
	[N/P]
Former [2010/37]	For all designated states GEORGETOWN UNIVERSITY 37th and "O" Streets, N.W. Washington, D.C. 20057 / US
	For all designated states SynerGene Therapeutics, Inc. 9812 Falls Road Suite 114 Potomac, MD 20854-3963 / US
Former [2001/37]	For all designated states GEORGETOWN UNIVERSITY 37th and "O" Streets, N.W. Washington, D.C. 20057 / US
	For all designated states Synergene Therapeutics Inc. 2022 R Street, N.W. Washington, DC 20009-1012 / US
Inventor(s)	01 / CHANG, Esther, H. 10244 Democracy Blvd Potomac, MD 20854 / US
	02 / PIROLLO, Kathleen 547 Anderson Avenue Rockville, MD 20850 / US
	03 / XU, Liang 186 Wild Ivy Ct Ann Arbor, MI 48103 / US
	04 / ALEXANDER, William 5336 Trailway Dr Rockville, MD 20853 / US
	[2010/36]
Former [2001/43]	01 / CHANG, Esther, H. 7508 Vale Street Chevy Chase, MD 20815 / US
	02 / PIROLLO, Kathleen 547 Anderson Avenue Rockville, MD 20850 / US
	03 / XU, Liang 1200 N. Queen Street 608 Arlington, VA 22209 / US
	04 / ALEXANDER, William 1211 Allison Drive Rockville, MD 20851 / US
Former [2001/37]	01 / CHANG, Esther, H. 7508 Vale Street Chevy Chase, MD 20815 / US
	02 / PIROLLO, Kathleen 547 Anderson Avenue Rockville, MA 20850 / US
	03 / XU, Liang 1200 N. Queen Street 608 Arlington, VA 22209 / US
	04 / ALEXANDER, William 1211 Allison Drive Rockville, MD 20851 / US
Representative(s)	Daniels, Jeffrey Nicholas, et al Page White & Farrer Limited Bedford House 21A John Street London WC1N 2BF / GB
	[N/P]
Former [2001/37]	Daniels, Jeffrey Nicholas, et al Page White & Farrer 54 Doughty Street London WC1N 2LS / GB
Application number, filing date	99959034.2	19.11.1999
	[2001/37]
	WO1999US27365
Priority number, date	US19980109236P	19.11.1998 Original published format: US 109236 P
	US19990128330P	08.04.1999 Original published format: US 128330 P
	[2001/37]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0029600
	Date:	25.05.2000
	Language:	EN
	[2000/21]
	Type:	A1 Application with search report
	No.:	EP1131457
	Date:	12.09.2001
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 25.05.2000 takes the place of the publication of the European patent application.
	[2001/37]
	Type:	B1 Patent specification
	No.:	EP1131457
	Date:	06.10.2010
	Language:	EN
	[2010/40]
Search report(s)	International search report - published on:	EP	25.05.2000
Classification	IPC:	C12N15/86, C12N15/87, A61K48/00, A61K47/48, A61K38/17	[2001/37]
	CPC:	C12N15/86 (EP); A61K38/1709 (EP); A61K47/6901 (EP); A61K48/00 (EP); A61P35/00 (EP); C12N15/87 (EP); (+) C12N2710/10343 (EP); C12N2710/10345 (EP) (-)
	C-Set:	A61K38/1709, A61K2300/00 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2001/37]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
	RO	Not yet paid
	SI	Not yet paid
Title	German:	SYSTEMISCHES VIRUS/LIGAND GENABGABEMITTEL UND GENTHERAPIE	[2001/37]
	English:	SYSTEMIC VIRAL/LIGAND GENE DELIVERY SYSTEM AND GENE THERAPY	[2001/37]
	French:	SYSTEME D'APPORT GENIQUE SYSTEMIQUE DE VIRUS/LIGANDS ET DE THERAPIE GENIQUE	[2001/37]
Entry into regional phase	12.06.2001	National basic fee paid
	12.06.2001	Designation fee(s) paid
	12.06.2001	Examination fee paid
Examination procedure	16.06.2000	Request for preliminary examination filed International Preliminary Examining Authority: EP
	12.06.2001	Examination requested [2001/37]
	24.05.2004	Despatch of a communication from the examining division (Time limit: M06)
	22.03.2005	Reply to a communication from the examining division
	19.05.2005	Despatch of a communication from the examining division (Time limit: M06)
	20.03.2006	Reply to a communication from the examining division
	23.05.2006	Despatch of a communication from the examining division (Time limit: M04)
	29.09.2006	Reply to a communication from the examining division
	05.02.2007	Despatch of a communication from the examining division (Time limit: M06)
	14.08.2007	Reply to a communication from the examining division
	21.09.2007	Despatch of a communication from the examining division (Time limit: M06)
	08.05.2008	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	13.06.2008	Reply to a communication from the examining division
	29.10.2008	Despatch of a communication from the examining division (Time limit: M06)
	21.04.2009	Reply to a communication from the examining division
	24.11.2009	Despatch of a communication from the examining division (Time limit: M04)
	09.02.2010	Reply to a communication from the examining division
	08.04.2010	Communication of intention to grant the patent
	30.07.2010	Fee for grant paid
	30.07.2010	Fee for publishing/printing paid
Opposition(s)	07.07.2011	No opposition filed within time limit [2011/37]
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the examination report
	13.06.2008	Request for further processing filed
	13.06.2008	Full payment received (date of receipt of payment)
	22.03.2005	Request for further processing filed
	22.03.2005	Full payment received (date of receipt of payment) Request granted
	06.04.2005	Decision despatched
	20.03.2006	Request for further processing filed
	20.03.2006	Full payment received (date of receipt of payment) Request granted
	04.04.2006	Decision despatched
Fees paid	Renewal fee
	27.11.2001	Renewal fee patent year 03
	25.11.2002	Renewal fee patent year 04
	21.11.2003	Renewal fee patent year 05
	22.11.2004	Renewal fee patent year 06
	29.11.2005	Renewal fee patent year 07
	13.11.2006	Renewal fee patent year 08
	16.11.2007	Renewal fee patent year 09
	17.11.2008	Renewal fee patent year 10
	24.11.2009	Renewal fee patent year 11
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	06.10.2010
	DK	06.10.2010
	FI	06.10.2010
	SE	06.10.2010
	LU	19.11.2010
	CH	30.11.2010
	LI	30.11.2010
	MC	30.11.2010
	GR	07.01.2011
	[2012/44]
Former [2012/37]	CY	06.10.2010
	DK	06.10.2010
	FI	06.10.2010
	SE	06.10.2010
	CH	30.11.2010
	LI	30.11.2010
	MC	30.11.2010
	GR	07.01.2011
Former [2011/38]	DK	06.10.2010
	FI	06.10.2010
	SE	06.10.2010
	CH	30.11.2010
	LI	30.11.2010
	MC	30.11.2010
	GR	07.01.2011
Former [2011/35]	FI	06.10.2010
	SE	06.10.2010
	CH	30.11.2010
	LI	30.11.2010
	MC	30.11.2010
	GR	07.01.2011
Former [2011/29]	FI	06.10.2010
	SE	06.10.2010
	MC	30.11.2010
	GR	07.01.2011
Cited in	International search	[DA]WO9424299 (BOEHRINGER INGELHEIM INT [DE], et al);
		[X]WO9738723 (IMMUSOL INC [US], et al);
		[X]WO9840508 (SOSNOWSKI BARBARA A [US], et al);
	by applicant	WO9206180
		US5108921
		US5139941
		US5288641
		US5378457
		US5416016
		US5521291
		US5547932
		US5635382
		US5693509
		US5762938
		WO9840508
		US5833975

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p